Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne K Lange

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|May 24, 2006
Docetaxel-associated epiphoraPolly E Kintzel, Laura B Michaud, Marianne K Lange
The American Surgeon|March 23, 2007
Squamous cell carcinoma of the scrotum in a radiation technologist and the use of sentinel lymph node biopsy in recurrent diseaseDavid A Shifrin, Marianne K Lange, Richard J Kahnoski, et al.
Cancer|October 13, 2007
Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026Laura F Hutchins, James Moon, Joseph I Clark, et al.
American Journal of Clinical Oncology|June 3, 2009
A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312Peter J Van Veldhuizen, Michael Hussey, Primo N Lara, et al.
BJU International|November 6, 2009
Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urotheliumDaniel P Petrylak, Catherine M Tangen, Peter J Van Veldhuizen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|May 24, 2006
Docetaxel-associated epiphoraPolly E Kintzel, Laura B Michaud, Marianne K Lange
The American Surgeon|March 23, 2007
Squamous cell carcinoma of the scrotum in a radiation technologist and the use of sentinel lymph node biopsy in recurrent diseaseDavid A Shifrin, Marianne K Lange, Richard J Kahnoski, et al.
Cancer|October 13, 2007
Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026Laura F Hutchins, James Moon, Joseph I Clark, et al.
American Journal of Clinical Oncology|June 3, 2009
A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312Peter J Van Veldhuizen, Michael Hussey, Primo N Lara, et al.
BJU International|November 6, 2009
Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urotheliumDaniel P Petrylak, Catherine M Tangen, Peter J Van Veldhuizen, et al.
Pageof 1